Evidence map›Paper›PMID 30315362›Full record

ArticlePsychopharmacology2018

Effects of Parkinson's disease and dopamine on digit span measures of working memory.

John Patrick Grogan, Lisa Emily Knight, Laura Smith, Nerea Irigoras Izagirre, Alexandra Howat, Brogan Elizabeth Knight, Anastasia Bickerton, Hanna Kristiina Isotalus, Elizabeth Jane Coulthard

Abstract read
In one paragraph

Article in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Attention/Working Memory and Executive Function in Parkinson's Disease: Review, Critique, and Recommendations.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
  9. Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Restorative Effects of Observing Natural and Urban Scenery after Working Memory Depletion.International journal of environmental research and public health · 2022
    Article
  16. Article
  17. Article
  18. Dopamine effects on memory load and distraction during visuospatial working memory in cognitively normal Parkinson's disease.Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

John Patrick GroganBristol Brain Centre, Elgar House, Southmead Hospital, Bristol, BS10 5NB, UK. John.grogan@bristol.ac.uk.ORCID http://orcid.org/0000-0002-0463-8904
Lisa Emily KnightUniversity Hospitals Bristol, Bristol, UK.
Laura SmithBristol Brain Centre, Elgar House, Southmead Hospital, Bristol, BS10 5NB, UK.
Nerea Irigoras IzagirreBristol Brain Centre, Elgar House, Southmead Hospital, Bristol, BS10 5NB, UK.
Alexandra HowatBristol Brain Centre, Elgar House, Southmead Hospital, Bristol, BS10 5NB, UK.
Brogan Elizabeth KnightNorth Bristol NHS Trust, Bristol, UK.
Anastasia BickertonBristol Brain Centre, Elgar House, Southmead Hospital, Bristol, BS10 5NB, UK.
Hanna Kristiina IsotalusBristol Brain Centre, Elgar House, Southmead Hospital, Bristol, BS10 5NB, UK.
Elizabeth Jane CoulthardBristol Brain Centre, Elgar House, Southmead Hospital, Bristol, BS10 5NB, UK.

Funding

BRACE BRI17/15Wellcome TrustWellcome Trust (GB) 097081/Z/11/Z
6 · The paper itself

Abstract

rationaleParkinson's disease (PD) impairs working memory (WM)-the ability to maintain items in memory for short periods of time and manipulate them. There is conflicting evidence on the nature of the deficits caused by the disease, and the potential beneficial and detrimental effects of dopaminergic medication on different WM processes.

objectivesWe hypothesised that PD impairs both maintenance and manipulation of items in WM and dopaminergic medications improve this in PD patients but impair it in healthy older adults.

methodsWe tested 68 PD patients ON and OFF their dopaminergic medication, 83 healthy age-matched controls, and 30 healthy older adults after placebo and levodopa administration. We used the digit span, a WM test with three components (forwards, backwards, and sequence recall) that differ in the amount of manipulation required. We analysed the maximum spans and the percentage of lists correctly recalled, which probe capacity of WM and the accuracy of the memory processes within this capacity, respectively.

resultsPD patients had lower WM capacity across all three digit span components, but only showed reduced percentage accuracy on the components requiring manipulation (backwards and sequence spans). Dopaminergic medication did not affect performance in PD patients. In healthy older adults, levodopa did not affect capacity, but did impair accuracy on one of the manipulation components (sequence), without affecting the other (backwards).

conclusionsThis suggests that the deficit of maintenance capacity and manipulation accuracy in PD patients is not primarily a dopaminergic one and supports a potential "overdosing" of intact manipulation mechanisms in healthy older adults by levodopa.

Indexed as

AgedAged, 80 and overDopamine AgentsFemaleHumansLevodopaMaleMemory, Short-TermMental RecallMiddle AgedNeuropsychological TestsParkinson DiseaseDopamine AgentsLevodopaDopamineLevodopaParkinson’s diseaseShort-term memoryWorking memory

Identifiers

PMID30315362
PMCPMC6267128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.